Pharma Focus Asia
Eppendorf Bioprocess Solutions

Tonix Pharmaceuticals Plans New Clinical Scale Manufacturing Facility in US


Tonix Pharmaceuticals Holding Corp, plans to open new manufacturing facility. The new R&D facility will address Advanced Development Center (ADC) for vaccine programs.


The new Advanced Development Center (ADC) will support research, development and analytical capabilities which also includes the production of quality trial vaccines for infectious diseases such as COVID-19.

The Advanced Development Center (ADC),comprises of single-use bioreactors and purification suites. Moreover when the facility becomes fully operational, Good Manufacturing Practice (GMP) production of vaccines for clinical trialswill have the capacity to produce sterile vaccines in glass bottles.

The facility is expected to hire 70 employees including scientists, researchers, manufacturing and technical support staff.

The construction of the site has begun and expected to be fully operational in first half of 2022.


NameTonix Pharmaceuticals
TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEAMasterControl - Simplify CAPA in 7 StepsTFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile App3rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023CPHI & PMEC China 2023Pharma Regulatory Conclave 2023Thermo Fisher Scientific - QualTrak